These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35964541)

  • 1. Voice biomarkers as indicators of cognitive changes in middle and later adulthood.
    Mahon E; Lachman ME
    Neurobiol Aging; 2022 Nov; 119():22-35. PubMed ID: 35964541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semantic item-level metrics relate to future memory decline beyond existing cognitive tests in older adults without dementia.
    Vonk JMJ; Geerlings MI; Avila-Rieger JF; Qian CL; Schupf N; Mayeux R; Brickman AM; Manly JJ
    Psychol Aging; 2023 Aug; 38(5):443-454. PubMed ID: 37199965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    Silva D; Cardoso S; Guerreiro M; Maroco J; Mendes T; Alves L; Nogueira J; Baldeiras I; Santana I; de Mendonça A
    J Alzheimers Dis; 2020; 74(3):785-796. PubMed ID: 32083585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Robust norms for neuropsychological tests of verbal episodic memory in Australian women.
    Goodwill AM; Campbell S; Henderson VW; Gorelik A; Dennerstein L; McClung M; Szoeke C
    Neuropsychology; 2019 May; 33(4):581-595. PubMed ID: 30829514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.
    Lim YY; Maruff P; Pietrzak RH; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Szoeke C; Martins RN; Masters CL; Villemagne VL; Rowe CC;
    Brain; 2014 Jan; 137(Pt 1):221-31. PubMed ID: 24176981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voice Markers of Lexical Access in Mild Cognitive Impairment and Alzheimer's Disease.
    Meilan JJG; Martinez-Sanchez F; Carro J; Carcavilla N; Ivanova O
    Curr Alzheimer Res; 2018; 15(2):111-119. PubMed ID: 28847280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for Reduced Autobiographical Memory Episodic Specificity in Cognitively Normal Middle-Aged and Older Individuals at Increased Risk for Alzheimer's Disease Dementia.
    Grilli MD; Wank AA; Bercel JJ; Ryan L
    J Int Neuropsychol Soc; 2018 Nov; 24(10):1073-1083. PubMed ID: 30136918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquisition and consolidation of verbal learning and episodic memory as predictors of the conversion from mild cognitive impairment to probable Alzheimer's disease.
    López-Pérez J; García-Herranz S; Díaz-Mardomingo MDC
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2023 Jul; 30(4):638-653. PubMed ID: 35475773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary investigation of cognitive function in aged multiple sclerosis patients: Challenges in detecting comorbid Alzheimer's disease.
    Roy S; Drake A; Snyder S; Cline B; Khan A; Fuchs T; Zivadinov R; Weinstock-Guttman B; Szigeti K; Benedict RHB
    Mult Scler Relat Disord; 2018 May; 22():52-56. PubMed ID: 29574353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Automatized FACEmemory® scoring is related to Alzheimer's disease phenotype and biomarkers in early-onset mild cognitive impairment: the BIOFACE cohort.
    Alegret M; Sotolongo-Grau O; de Antonio EE; Pérez-Cordón A; Orellana A; Espinosa A; Gil S; Jiménez D; Ortega G; Sanabria A; Roberto N; Hernández I; Rosende-Roca M; Tartari JP; Alarcon-Martin E; de Rojas I; Montrreal L; Morató X; Cano A; Rentz DM; Tárraga L; Ruiz A; Valero S; Marquié M; Boada M
    Alzheimers Res Ther; 2022 Mar; 14(1):43. PubMed ID: 35303916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological measures that detect early impairment and decline in preclinical Alzheimer disease.
    Schindler SE; Jasielec MS; Weng H; Hassenstab JJ; Grober E; McCue LM; Morris JC; Holtzman DM; Xiong C; Fagan AM
    Neurobiol Aging; 2017 Aug; 56():25-32. PubMed ID: 28482211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depressive symptoms influence global cognitive impairment indirectly by reducing memory and executive function in patients with mild cognitive impairment.
    Yatawara C; Lim L; Chander R; Zhou J; Kandiah N
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1375-1383. PubMed ID: 28103200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Episodic memory of odors stratifies Alzheimer biomarkers in normal elderly.
    Dhilla Albers A; Asafu-Adjei J; Delaney MK; Kelly KE; Gomez-Isla T; Blacker D; Johnson KA; Sperling RA; Hyman BT; Betensky RA; Hastings L; Albers MW
    Ann Neurol; 2016 Dec; 80(6):846-857. PubMed ID: 27696605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding heterogeneity in older adults: Latent growth curve modeling of cognitive functioning.
    MacAulay RK; Calamia MR; Cohen AS; Daigle K; Foil H; Brouillette R; Bruce-Keller AJ; Keller JN
    J Clin Exp Neuropsychol; 2018 Apr; 40(3):292-302. PubMed ID: 28669314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
    Racine AM; Clark LR; Berman SE; Koscik RL; Mueller KD; Norton D; Nicholas CR; Blennow K; Zetterberg H; Jedynak B; Bilgel M; Carlsson CM; Christian BT; Asthana S; Johnson SC
    J Alzheimers Dis; 2016 Oct; 54(4):1395-1408. PubMed ID: 27589532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Utility of Language and Voice Biomarkers to Predict Cognitive Impairment in the Framingham Heart Study Cognitive Aging Cohort Data.
    Thomas JA; Burkhardt HA; Chaudhry S; Ngo AD; Sharma S; Zhang L; Au R; Hosseini Ghomi R
    J Alzheimers Dis; 2020; 76(3):905-922. PubMed ID: 32568190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episodic-Memory Performance in Machine Learning Modeling for Predicting Cognitive Health Status Classification.
    Bergeron MF; Landset S; Tarpin-Bernard F; Ashford CB; Khoshgoftaar TM; Ashford JW
    J Alzheimers Dis; 2019; 70(1):277-286. PubMed ID: 31177223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.